From 1 July 2025, when Pharmac funds a new cancer medicine or widens access to existing funded cancer medicines, eligible patients will be able to receive the publicly funded medicine within private facilities for a period of up to 12 months without having to move their care to a public hospital.
Email: [email protected]
